5 January 2022
\n \n \n \nA \u00a3210,000 donation from the Alan Davidson Foundation has been made to our Department to advance our world-leading research into Motor Neuron Disease. The funding will support a project manager to deliver an innovative research project using the genetic causes of MND to develop approaches to early diagnosis.
\n \n\n \n \n13 December 2021
\n \n \n \nScientists have observed the clumping of alpha-synuclein in the cerebrospinal fluid taken from people with Parkinson's. The findings offer hope that a pioneering new clinical test could be developed to diagnose Parkinson's correctly in its early stages.
\n \n\n \n \n19 November 2021
\n \n \n \nIn May 2020 our researchers initiated a global project to investigate how COVID-19 has affected people with epilepsy, their carers and health care workers.
\n \n\n \n \n11 November 2021
\n \n \n \n\n \n \n3 November 2021
\n \n \n \nMembers of the European Platform for Neurodegenerative Diseases (EPND) will establish a collaborative platform for efficient sample and data sharing, linking existing European research infrastructures to accelerate the discovery of biomarkers, new diagnostics and treatments for the benefit of people with neurodegenerative diseases such as Alzheimer's and Parkinson's.
\n \n\n \n \n27 October 2021
\n \n \n \nResearch reveals risks of developing neurological complications following a positive COVID-19 PCR test, or a first dose of either the Oxford-AstraZeneca or Pfizer-BioNTech COVID-19 vaccinations.
\n \n\n \n \n26 October 2021
\n \n \n \nA major new $9 million project funded by the Aligning Science Across Parkinson\u2019s (ASAP) initiative will map the original circuits vulnerable to Parkinson\u2019s on an unprecedented scale. The project is a collaboration between core investigators Stephanie Cragg, Richard Wade-Martins, and Peter Magill at Oxford, Mark Howe at Boston University and Dinos Meletis at the Karolinska Institutet, as well as collaborators Yulong Li at Peking University and Michael Lin at Stanford University.
\n \n\n \n \n8 October 2021
\n \n \n \nMapping brain network activity from structural connectivity using deep learning
\n \n\n \n \n30 September 2021
\n \n \n \nResearchers at Oxford University have received a prestigious Wellcome Innovator Grant for investigating the role of the pedunculopontine nucleus (PPN) \u2013 a brainstem nucleus \u2013 in human consciousness.
\n \n\n \n \n17 September 2021
\n \n \n \nGreater understanding of the role of lipoproteins could support screening and efforts to develop treatments.
\n \n\n \n \n10 September 2021
\n \n \n \n\n \n \n8 September 2021
\n \n \n \nAlex is one of eight Oxford University academics who have been awarded significant financial funding from the UKRI Future Leaders Fellowships Scheme
\n \n\n \n \n7 September 2021
\n \n \n \nPatients with autoantibodies which target neuronal proteins can have pain as an under-recognised clinical manifestation.
\n \n\n \n \n22 July 2021
\n \n \n \n\n \n \n22 June 2021
\n \n \n \nThe Medical Research Council awarded Dr John Jacob upwards of \u00a3200,000 to fund a project on brain cancer modelling.
\n \n\n \n \n21 June 2021
\n \n \n \n\n \n \n28 May 2021
\n \n \n \nProfessor David Bennett is leading a new national research consortium to investigate neuropathic pain.
\n \n\n \n \n16 February 2021
\n \n \n \nResearchers have revealed a disease-causing population of immune cells, which travel to the brain in patients with multiple sclerosis. They demonstrate how to trap these cells in the blood, which means they can be targeted to prevent disease progression.
\n \n\n \n \n26 November 2020
\n \n \n \nTwo of our Associate Professors, Sarosh Irani and George Tofaris, have been awarded MRC Senior Clinical Fellowships.
\n \n\n \n \n26 November 2020
\n \n \n \nAssociate Professor Sarosh Irani, who heads up our Autoimmune Neurology Group, has been funded by Mologic to help develop diagnostics for COVID-19.
\n \n\n \n \n